These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 14632883)

  • 1. Breast conserving surgery: adequate local clearance of the cancer is mandatory.
    Malycha PL
    ANZ J Surg; 2003 Dec; 73(12):973-4. PubMed ID: 14632883
    [No Abstract]   [Full Text] [Related]  

  • 2. Margin status after breast-conserving treatment of breast cancer: how much free margin is enough?
    von Smitten K
    J Surg Oncol; 2008 Dec; 98(8):585-7. PubMed ID: 19072849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast conserving surgery for multifocal breast cancer.
    Lim W; Park EH; Choi SL; Seo JY; Kim HJ; Chang MA; Ku BK; Son B; Ahn SH
    Ann Surg; 2009 Jan; 249(1):87-90. PubMed ID: 19106681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting and preventing positive surgical margins and local failures in breast-conserving surgery.
    Ziogas D; Ignatiadou E; Fatouros M
    Ann Surg Oncol; 2009 Feb; 16(2):544-5. PubMed ID: 19050960
    [No Abstract]   [Full Text] [Related]  

  • 5. [Breast cancer surgery].
    Vlastos G; Berclaz G; Langer I; Pittet-Cuenod B; Delaloye JF
    Rev Med Suisse; 2007 Oct; 3(130):2389-90, 2392-5. PubMed ID: 18062502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Completion mastectomy after breast conserving surgery.
    O'Donnell ME; Salem A; Badger SA; Sharif MA; Lioe T; Spence RA
    Breast; 2008 Apr; 17(2):199-204. PubMed ID: 18024117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual specimen cellularity after neoadjuvant chemotherapy for breast cancer.
    Peintinger F; Kuerer HM; McGuire SE; Bassett R; Pusztai L; Symmans WF
    Br J Surg; 2008 Apr; 95(4):433-7. PubMed ID: 18161887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of local recurrence as a prognostic factor in the treatment of breast cancer.
    Horiguchi J; Koibuchi Y; Yoshida T; Takata D; Kikuchi M; Rokutanda N; Nagaoka R; Iino Y; Morishita Y
    Anticancer Res; 2006; 26(1B):569-73. PubMed ID: 16739322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update).
    Holmes DR; Baum M; Joseph D
    Am J Surg; 2007 Oct; 194(4):507-10. PubMed ID: 17826067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and trends of surgical modalities for breast cancer in China: a review of 16-year data.
    Yu KD; Di GH; Wu J; Lu JS; Shen KW; Shen ZZ; Shao ZM
    Ann Surg Oncol; 2007 Sep; 14(9):2502-9. PubMed ID: 17564750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
    Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
    Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients.
    Garimella V; Qutob O; Fox JN; Long ED; Chaturvedi A; Turnbull LW; Drew PJ
    Eur J Surg Oncol; 2007 Mar; 33(2):157-61. PubMed ID: 17085007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment.
    Petit JY; Veronesi U; Orecchia R; Luini A; Rey P; Intra M; Didier F; Martella S; Rietjens M; Garusi C; DeLorenzi F; Gatti G; Leon ME; Casadio C
    Breast Cancer Res Treat; 2006 Mar; 96(1):47-51. PubMed ID: 16261402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient age and positive margins are predictive factors of residual tumor on mastectomy specimen after conservative treatment for breast cancer.
    Voguet L; Hébert T; Levêque J; Acker O; Mesbah H; Marret H; Porée P; Body G
    Breast; 2009 Aug; 18(4):233-7. PubMed ID: 19628389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.
    Monteau A; Sigal-Zafrani B; Kirova YM; Fourchotte V; Bollet MA; Vincent-Salomon A; Asselain B; Salmon RJ; Fourquet A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1021-8. PubMed ID: 19386441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer.
    Aziz D; Rawlinson E; Narod SA; Sun P; Lickley HL; McCready DR; Holloway CM
    Breast J; 2006; 12(4):331-7. PubMed ID: 16848842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of residual glandular tissue after skin-sparing mastectomies.
    Torresan RZ; dos Santos CC; Okamura H; Alvarenga M
    Ann Surg Oncol; 2005 Dec; 12(12):1037-44. PubMed ID: 16244800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing local recurrence after breast-conserving surgery for breast cancer.
    Liakakos T; Baltogiannis G
    Ann Surg Oncol; 2008 Mar; 15(3):949-50. PubMed ID: 17922227
    [No Abstract]   [Full Text] [Related]  

  • 19. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy.
    Evans RA
    Cancer; 2003 Dec; 98(11):2522-3; author reply 2523-4. PubMed ID: 14635089
    [No Abstract]   [Full Text] [Related]  

  • 20. [Margin status in invasive breast cancer].
    Houvenaeghel G; Lambaudie E; Buttarelli M; Cohen M; Bannier M; Tallet A; Jacquemier J
    Bull Cancer; 2008 Dec; 95(12):1161-70. PubMed ID: 19091649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.